Medifast (MED) Tops Q4 EPS by 19c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.95 -0.08%
EPS Growth %: -195.2%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -195.2%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $1.09, $0.19 better than the analyst estimate of $0.90. Revenue for the quarter came in at $191 million versus the consensus estimate of $184.17 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Lucid Capital Markets Starts Bain Capital Specialty Finance (BCSF) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
